REVIEW article
Front. Psychiatry
Sec. Psychopharmacology
Volume 16 - 2025 | doi: 10.3389/fpsyt.2025.1594730
This article is part of the Research TopicPost-Operative Neuropsychiatric Disorders, volume IIView all 5 articles
The Impact of Ketamine on Cognitive Outcomes in Geriatric Anesthesia: A Comprehensive Review
Provisionally accepted
Shuyong You*
Zhaohui Li- Luxian People’s Hospital, Luzhou, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Background: Ketamine, a dissociative anesthetic with N-methyl-D-aspartate (NMDA) receptor blockade, has become increasingly popular in geriatric anesthesia because of its hemodynamic stability, lack of respiratory depression, and possible neuroprotective properties. Yet, its effect on cognitive function in elderly surgical patients is unknown. Postoperative cognitive dysfunction (POCD) and postoperative delirium (POD) are frequent complications in elderly surgical patients, resulting in longer hospital stays, higher healthcare costs, and long-term cognitive impairment. Although there is some evidence to support ketamine in decreasing neuroinflammation and maintaining cognitive function, others describe high risks of delirium and hallucination, especially at higher doses.Methods: This review assessed the existing literature on ketamine's impact on cognitive outcomes in older anesthesia. A comprehensive review of randomized controlled trials (RCTs was performed, assessing ketamine's potential to prevent or worsen POCD and POD. Results: Results show that low-dose ketamine (0.3–0.5 mg/kg) is neuroprotective and decreases the rate of cognitive dysfunction in certain patients. Nevertheless, findings continue to be at odds because study design, population of patients, dosing schedules, and measure of cognition may differ. Secondly, the weighting of ketamine's neuroprotective and neurotoxic effects is dose-dependent with larger doses inducing unwanted neuropsychiatric impacts.Conclusion: In light of these divergent results, additional large-scale, multicenter RCTs are needed to establish optimal dosing regimens and to identify elderly patient subgroups that could be treated safely with ketamine to avoid cognitive complications. Multimodal techniques of anesthesia and long-term cognitive outcomes will also need to be studied in future studies to further delineate ketamine's definitive place in geriatric anesthesia.
Keywords: Ketamine, Geriatric anesthesia, postoperative cognitive dysfunction, postoperative delirium, Neuroprotection, NMDA receptor antagonist
Received: 16 Mar 2025; Accepted: 09 Jun 2025.
Copyright: © 2025 You and Li. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Shuyong You, Luxian People’s Hospital, Luzhou, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.